6-aminonicotinamide has been researched along with metallothionein in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hidalgo, J; Moos, T; Penkowa, M | 1 |
| Giralt, M; Hernández, J; Hidalgo, J; Moos, T; Penkowa, M; Thomsen, PS | 1 |
| Hidalgo, J; Penkowa, M | 1 |
| Camats, J; Giralt, M; Hidalgo, J; Penkowa, M | 1 |
| Carrasco, J; Hidalgo, J; Penkowa, M; Poulsen, C | 1 |
| Camats, J; Campbell, IL; Giralt, M; Hadberg, H; Hidalgo, J; Molinero, A; Penkowa, M; Quintana, A; Rojas, S | 1 |
| Carrasco, J; Giralt, M; Hidalgo, J; Molinero, A; Penkowa, M; Quintana, A | 1 |
| Penkowa, M | 1 |
1 review(s) available for 6-aminonicotinamide and metallothionein
| Article | Year |
|---|---|
Metallothionein I + II expression and roles during neuropathology in the CNS.
Topics: 6-Aminonicotinamide; Animals; Brain; Brain Diseases; Brain Injuries; Central Nervous System; Central Nervous System Diseases; DNA Fragmentation; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Inflammation Mediators; Lymphocyte Activation; Macrophages; Metallothionein; Necrosis; Neovascularization, Pathologic; Neurofibrillary Tangles; Oxidative Stress; Tumor Necrosis Factor-alpha | 2006 |
7 other study(ies) available for 6-aminonicotinamide and metallothionein
| Article | Year |
|---|---|
Increased astrocytic expression of metallothioneins I + II in brainstem of adult rats treated with 6-aminonicotinamide.
Topics: 6-Aminonicotinamide; Animals; Astrocytes; Blood-Brain Barrier; Brain Stem; Glial Fibrillary Acidic Protein; Macrophages; Metallothionein; Microglia; Rats; Rats, Wistar; Serum Albumin; Tissue Distribution | 1997 |
Impaired inflammatory response to glial cell death in genetically metallothionein-I- and -II-deficient mice.
Topics: 6-Aminonicotinamide; Animals; Astrocytes; Blood-Brain Barrier; Bone Marrow Cells; Cell Death; Coloring Agents; Granulocyte-Macrophage Colony-Stimulating Factor; Immunohistochemistry; Inflammation; Lectins; Macrophages; Metallothionein; Mice; Mice, Knockout; Microglia; Niacin; Receptors, Granulocyte Colony-Stimulating Factor; Zinc | 1999 |
IL-6 deficiency leads to reduced metallothionein-I+II expression and increased oxidative stress in the brain stem after 6-aminonicotinamide treatment.
Topics: 6-Aminonicotinamide; Animals; Antigens, Differentiation; Astrocytes; Blood-Brain Barrier; Bone Marrow Cells; Brain Stem; Encephalitis; Glial Fibrillary Acidic Protein; Hematopoiesis; Immunohistochemistry; Interleukin-6; Macrophages; Malondialdehyde; Metallothionein; Metallothionein 3; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Nerve Tissue Proteins; Oxidative Stress; Protein Isoforms; Serum Albumin; T-Lymphocytes; Tyrosine | 2000 |
Metallothionein 1+2 protect the CNS during neuroglial degeneration induced by 6-aminonicotinamide.
Topics: 6-Aminonicotinamide; Animals; Central Nervous System; Female; Male; Metallothionein; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Nerve Degeneration; Neuroglia; Teratogens | 2002 |
M-CSF deficiency leads to reduced metallothioneins I and II expression and increased tissue damage in the brain stem after 6-aminonicotinamide treatment.
Topics: 6-Aminonicotinamide; Animals; Antioxidants; Apoptosis; Astrocytes; Brain Stem; Caspases; Encephalitis; Fluorescent Antibody Technique; Glial Fibrillary Acidic Protein; Homozygote; In Situ Nick-End Labeling; Lymphocytes; Macrophage Colony-Stimulating Factor; Macrophages; Metallothionein; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Microglia; Niacin; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidative Stress | 2002 |
Astrocyte-targeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide.
Topics: 6-Aminonicotinamide; Angiogenesis Inducing Agents; Animals; Apoptosis; Astrocytes; Brain Stem; Cell Count; Central Nervous System; Cytokines; Disease Models, Animal; Gene Targeting; Glial Fibrillary Acidic Protein; Growth Substances; Immunohistochemistry; In Situ Nick-End Labeling; Interleukin-6; Lymphocytes; Macrophages; Malondialdehyde; Metallothionein; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Nerve Degeneration; Oxidative Stress; Staining and Labeling; Stem Cells; Teratogens; Tyrosine | 2003 |
Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide.
Topics: 6-Aminonicotinamide; Animals; Apoptosis; Brain Stem; Caspase 3; Caspases; Crosses, Genetic; Disease Models, Animal; Down-Regulation; Encephalitis; Free Radicals; Glial Fibrillary Acidic Protein; Gliosis; Interleukin-6; Metallothionein; Mice; Mice, Transgenic; Nerve Degeneration; Neurofibrillary Tangles; Neuroglia; Neuroprotective Agents; Neurotoxins; Oxidative Stress; Promoter Regions, Genetic | 2004 |